Embecta BMV:EMBC * Stock Report Company Financials + 3 Analysts
Embecta Corp.
BMV:EMBC * Stock Report
EMBC * Stock Overview A medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes.
Rewards Risk Analysis + 2 more risks
See All Risk Checks Embecta Corp. Competitors Price History & Performance
Summary of all time highs, changes and price drops for Embecta Historical stock prices Current Share Price US$497.96 52 Week High US$666.36 52 Week Low US$497.96 Beta 0 11 Month Change 0% 3 Month Change n/a 1 Year Change -9.13% 33 Year Change n/a 5 Year Change n/a Change since IPO -23.73%
Recent News & Updates
Embecta Corp. to Report Q4, 2024 Results on Nov 26, 2024 Nov 13
Embecta Corp. Receives 510(k) Clearance from the U.S. Food and Drug Administration for Disposable Insulin Delivery System Sep 03 Embecta Corp. Revises Earnings Guidance for the Fiscal Year 2024
Embecta Corp. to Report Q3, 2024 Results on Aug 09, 2024 Jul 19 Embecta Corp. Provides Earnings Guidance for the Fiscal Year 2024
Embecta Corp. to Report Q2, 2024 Results on May 09, 2024 Apr 24 See more updates
Embecta Corp. to Report Q4, 2024 Results on Nov 26, 2024 Nov 13
Embecta Corp. Receives 510(k) Clearance from the U.S. Food and Drug Administration for Disposable Insulin Delivery System Sep 03 Embecta Corp. Revises Earnings Guidance for the Fiscal Year 2024
Embecta Corp. to Report Q3, 2024 Results on Aug 09, 2024 Jul 19 Embecta Corp. Provides Earnings Guidance for the Fiscal Year 2024
Embecta Corp. to Report Q2, 2024 Results on May 09, 2024 Apr 24 Embecta Corp. Updates Earnings Guidance for the Fiscal Year 2024
Embecta Corp. to Report Q1, 2024 Results on Feb 09, 2024 Jan 25
Embecta Corp. Announces Food and Drug Administration 510(K) Submission for Insulin Patch Pump Jan 09
Embecta Corp., Annual General Meeting, Feb 07, 2024 Dec 20 Embecta Corp. to Report Q4, 2023 Results on Nov 21, 2023 Embecta Corp. Revises Earnings Guidance for the Fiscal Year 2023
Embecta Corp. Announces Resignation of Ajay Kumar as Chief Human Resources Officer, Effective July 16, 2023 Jul 06
Second quarter 2023 earnings released: EPS: US$0.24 (vs US$1.38 in 2Q 2022) May 17
High number of new and inexperienced directors May 17 Embecta Corp. Revises Revenue Guidance for the Fiscal Year 2023 Embecta Corp. Declares Quarterly Cash Dividend, Payable on March 13, 2023
First quarter 2023 earnings released Feb 15
High number of new and inexperienced directors Jan 30
Embecta Corp. to Report Q1, 2023 Results on Feb 14, 2023 Jan 25
High number of new and inexperienced directors Jan 05 Embecta Corp. Provides Revenue Guidance for the Fiscal Year 2023
Investor sentiment improved over the past week Dec 05
High number of new and inexperienced directors Nov 16
High number of new and inexperienced directors Oct 28
Embecta Corp., Annual General Meeting, Feb 09, 2023 Oct 01
Embecta Corp.(NasdaqGS:EMBC) dropped from FTSE All-World Index (USD) Sep 19
Third quarter 2022 earnings released Aug 16 Embecta Corp. Revises Revenue Guidance for the Second-Half Fiscal Year 2022
Embecta Corp. to Report Q3, 2022 Results on Aug 15, 2022 Jul 06
Embecta Corp. Provides Revenue Guidance for the Last Six Months of Fiscal Year 2022 May 14
Embecta Corp. to Report Q2, 2022 Results on May 13, 2022 Apr 20 Shareholder Returns EMBC * MX Medical Equipment MX Market 7D 0% 0% 0% 1Y -9.1% 0% 0%
See full shareholder returns
Return vs Market: EMBC * underperformed the MX Market which returned 3.7% over the past year.
Price Volatility Is EMBC *'s price volatile compared to industry and market? EMBC * volatility EMBC * Average Weekly Movement n/a Medical Equipment Industry Average Movement 0% Market Average Movement 0% 10% most volatile stocks in MX Market 0% 10% least volatile stocks in MX Market 0%
Stable Share Price: EMBC * has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine EMBC *'s volatility change over the past year.
About the Company Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing patient’s diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally.
Show more Embecta Corp. Fundamentals Summary How do Embecta's earnings and revenue compare to its market cap? EMBC * fundamental statistics Market cap Mex$20.30b Earnings (TTM ) Mex$802.88m Revenue (TTM ) Mex$18.94b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) EMBC * income statement (TTM ) Revenue US$1.11b Cost of Revenue US$368.50m Gross Profit US$745.00m Other Expenses US$697.80m Earnings US$47.20m
Last Reported Earnings
Jun 30, 2023
Earnings per share (EPS) 0.82 Gross Margin 66.91% Net Profit Margin 4.24% Debt/Equity Ratio -198.2%
How did EMBC * perform over the long term?
See historical performance and comparison Dividends
2.9% Current Dividend Yield When do you need to buy EMBC * by to receive an upcoming dividend? Embecta dividend dates Ex Dividend Date Aug 24 2023 Dividend Pay Date Sep 13 2023 Days until Ex dividend 447 days Days until Dividend pay date 427 days
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
